% Expired Patents = 75.0

Forward Citations = 208

Loading Chart...

6 inventors (with patents filed for the assignee):

Jeffrey Martin Gimble (3 out of 12 patents)

William O Wilkison (2 out of 17 patents)

John W Ludlow (1 out of 13 patents)

4. Jeffery M Gimble (1 out of 1 patent)

5. Padmavathy Vanguri (1 out of 1 patent)

6. Jon Konkle (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 9249393 - Adipose derived adult stem cells in hepatic regeneration (2016-02-02),

2. 7582292 - Adipose tissue derived stromal cells for the treatment of neurological disorders (2009-09-01),

3. 7078232 - Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof (2006-07-18),

4. 7078230 - Adipose tissue-derived stromal cell that expresses characteristics of a neuronal cell (2006-07-18),

Company Overview

Artecel, Inc is a leading biotechnology company specializing in regenerative medicine. With a focus on developing innovative cell therapies for various medical conditions, Artecel is dedicated to improving patient outcomes and quality of life. With a team of experienced scientists and researchers, Artecel is at the forefront of advancing cell-based therapies to address unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#544 in Sunnyvale, CA

#14,049 in California

#60,638 in US

Sunnyvale, CA, United States of America

Artecel, Inc

Forward Citations = 208

6 inventors:

Jeffrey Martin Gimble (3 out of 12 patents)

William O Wilkison (2 out of 17 patents)

John W Ludlow (1 out of 13 patents)

4. Jeffery M Gimble (1 out of 1 patent)

5. Padmavathy Vanguri (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Artecel, Inc. Retrieved from https://idiyas.com/company/artecel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]